GALERA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1826 USD | -1.88% |
|
-4.30% | +25.58% |
| Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
| Mar. 28 | Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Galera Therapeutics, Inc.
46d5920ed0a183.TYfv9xobMWej0Sqzr_DjdoRXwUVV8x7bmqEhROcK2Ks.IMi2snIiZxbiuBmFzaCXAsZkgjwSnnqeyekYEoxQ7pJ9ztqbU1UEI_ubRQ~b0857b1eac598e713b2c691254c27f58
Upcoming events on Galera Therapeutics, Inc.
Past events on Galera Therapeutics, Inc.
| 2024-03-28 07:00 am | Q4 2023 Earnings Release |
| 2023-11-14 07:00 am | Q3 2023 Earnings Release |
| 2023-09-11 04:30 pm | H.C. Wainwright Global Investment Conference - Fireside Chat |
| 2023-08-14 07:00 am | Q2 2023 Earnings Release |
| 2023-08-10 08:30 am | ROMAN Phase 3 Trial Results Call |
| 2023-06-14 10:00 am | Annual General Meeting |
| 2023-06-05 01:15 pm | American Society of Clinical Oncology Conference - Abstract No 6066 |
| 2023-05-11 07:00 am | Q1 2023 Earnings Release |
| 2023-03-10 04:00 am | ECHNO Congress - Abstract No - 93 |
| 2023-03-08 07:00 am | Q4 2022 Earnings Release |
| 2023-03-07 | European Head and Neck Oncology Congress |
| 2022-11-29 11:10 am | Piper Sandler Healthcare Conference |
| 2022-11-09 07:00 am | Q3 2022 Earnings Release |
| 2022-10-26 01:40 pm | American Society for Radiation Oncology Meeting - Abstract Number: 280 |
| 2022-10-26 11:50 am | American Society for Radiation Oncology Meeting - Abstract Number: 1124 |
| 2022-10-26 11:30 am | American Society for Radiation Oncology Meeting - Abstract Number: 2687 |
| 2022-10-23 05:45 pm | American Society for Radiation Oncology Meeting - Abstract Number: 2841 |
| 2022-09-12 04:30 pm | H.C. Wainwright Global Investment Conference |
| 2022-08-15 07:00 am | Interim 2022 Earnings Release |
| 2022-06-15 10:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -50,4 -49,7 -1.55% | -70,2 -71,0 1.14% | -72,6 -79,0 8.15% | -51,1 -51,1 0.01% |
|
EBIT Million USD | Released Forecast Spread | -50,7 -49,7 -1.94% | -70,6 -70,3 -0.36% | -73,4 -78,2 6.13% | -51,2 -51,0 -0.48% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,9 -52,0 0.12% | -74,2 -73,0 -1.67% | -80,5 -83,6 3.68% | -62,3 -61,6 -1.07% |
|
Net income Million USD | Released Forecast Spread | -59,1 -49,6 -19.2% | -74,2 -73,0 -1.61% | -80,5 -83,2 3.23% | -62,2 -61,1 -1.82% |
|
EPS USD | Released Forecast Spread | -2,38 -1,99 -19.6% | -2,98 -2,87 -3.71% | -3,12 -3,23 3.31% | -2,30 -2,23 -3.02% |
| Announcement Date | 10/03/20 | 11/03/21 | 10/03/22 | 08/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -11,9 -11,6 -2.51% | |||||||
|
EBIT Million USD | Released Forecast Spread | -14,5 -19,5 25.78% | -13,2 -12,6 -4.47% | -12,0 -12,0 0.61% | -13,0 -12,2 -6.07% | -13,2 -12,9 -2.26% | -13,9 -13,4 -3.59% | -16,8 -13,4 -25.43% | -11,1 -14,3 22.2% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,8 -19,9 15.48% | -15,4 -14,0 -10.54% | -14,6 -14,5 -0.17% | -16,0 -14,6 -9.7% | -16,3 -15,6 -4.24% | -17,7 -16,6 -6.62% | -20,7 -17,4 -18.97% | -15,1 -18,4 17.86% |
|
Net income Million USD | Released Forecast Spread | -16,8 -19,5 13.81% | -15,4 -14,0 -10.69% | -14,6 -13,6 -7.3% | -16,0 -13,9 -15.67% | -16,2 -15,1 -7.37% | -17,7 -14,4 -23.03% | -20,7 -17,4 -18.97% | -15,1 -18,4 17.86% |
|
EPS USD | Released Forecast Spread | -0,64 -0,74 13.12% | -0,58 -0,53 -9.43% | -0,54 -0,50 -7.29% | -0,60 -0,51 -16.88% | -0,58 -0,52 -11.54% | -0,50 -0,42 -20.48% | -0,48 -0,41 -18.52% | -0,33 -0,42 20.48% |
| Announcement Date | 10/03/22 | 16/05/22 | 09/08/22 | 09/11/22 | 08/03/23 | 11/05/23 | 14/08/23 | 14/11/23 |
More events
Past sector events for Galera Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GRTX Stock
- Calendar Galera Therapeutics, Inc.
